Literature DB >> 3981166

The relationship between serum concentrations and central nervous system actions of metoprolol.

F M Gengo, J C Ermer, C Carey, G C Kalonaros, W B McHugh.   

Abstract

The relationship between serum levels of metoprolol, hydroxymetoprolol and changes in psychomotor function as measured by standard reaction time and flash fusion frequency was studied. Blinded subjects were given placebo or 150 mg dose of metoprolol and crossed over on the next study day. Flash fusion frequency, reaction time, and serial blood levels of metoprolol and hydroxymetoprolol were collected. Oral dosing of metoprolol produced no significant changes in reaction time. However, significant decreases in flash fusion frequency were observed from 2 to 6 hours after the dose. Changes in flash fusion frequency were related to levels of metoprolol. Flash fusion frequency changes lagged behind the time course of metoprolol concentrations. The nadir of variance in the metoprolol plus hydroxymetoprolol concentration-effect relationship occurred when potency of hydroxymetoprolol was assumed to be 0.3 of metoprolol. These data suggest that the central nervous system actions of metoprolol are related to metoprolol serum levels and occur at low metoprolol concentrations. However, CNS effects of metoprolol do not intensify at high concentrations. Further CNS activity of hydroxymetoprolol may explain the lag seen in the relationship between concentration and CNS effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981166      PMCID: PMC1028207          DOI: 10.1136/jnnp.48.2.101

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Editorial: Non-beta-blocking actions of propranolol.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Flicker fusion frequency; background and applications.

Authors:  E SIMONSON; J BROZEK
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

3.  SHAM, a method for biexponential curve resolution using initial slope, height, area and moment of the experimental decay type curve.

Authors:  O Caprani; E Sveinsdottir; N Lassen
Journal:  J Theor Biol       Date:  1975-08       Impact factor: 2.691

4.  Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.

Authors:  P Collste; K O Borg; H Aström; C von Bahr
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

Review 5.  Effect of active drug metabolites on plasma level-response correlations.

Authors:  A J Atkinson; J M Strong
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

Review 6.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Kinetics of pharmacologic effects.

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1966 May-Jun       Impact factor: 6.875

8.  Effects of atenolol and propranolol on human performance and subjective feelings.

Authors:  A A Landauer; D A Pocock; F W Prott
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

9.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

10.  Plasma levels and beta-blocking effect of alpha-hydroxymetoprolol--metabolite of metoprolol--in the dog.

Authors:  C G Regårdh; L Ek; K J Hoffmann
Journal:  J Pharmacokinet Biopharm       Date:  1979-10
View more
  2 in total

1.  Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.

Authors:  E S Dimenäs; C G Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.

Authors:  T Kaila; R Marttila
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.